RP

Robert Pierce

Chief Scientific Officer

Eterna Therapeutics

Eterna Therapeutics Pipeline

DrugIndicationPhase
ERNA-101Platinum-Resistant Ovarian CancerPreclinical
ERNA-201Rheumatoid ArthritisPreclinical